Metraipolis › archive › dc_6007dbc3d0ef

Therapeutic Vulnerabilities of the Key Genetic Drivers in Leiomyosarcoma — Europe PMC PMID:42783444

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42783444
DOI
10.3390/medsci14050571
License (as archived)
solo-consultazione
Archived
2026-10-08T13:13:55.954Z
SHA-256 of the archived text
328eb99b3fd78fcd0937db97eb5bae452e334bfb7c727a041b009e6bc87527f0
Stable URL of this page
https://metraipolis.com/documento/dc_6007dbc3d0ef

How to cite

Therapeutic Vulnerabilities of the Key Genetic Drivers in Leiomyosarcoma — Europe PMC PMID:42783444 — Europe PMC (en), https://europepmc.org/article/MED/42783444 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6007dbc3d0ef (Metraipolis archive dc_6007dbc3d0ef, sha256 328eb99b3fd78fcd0937db97eb5bae452e334bfb7c727a041b009e6bc87527f0)
BibTeX
@misc{dc6007dbc3d0ef,
  title = {Therapeutic Vulnerabilities of the Key Genetic Drivers in Leiomyosarcoma — Europe PMC PMID:42783444},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42783444},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6007dbc3d0ef; sha256 328eb99b3fd78fcd0937db97eb5bae452e334bfb7c727a041b009e6bc87527f0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42783444. Agents can read the archived copy with the MCP tool read_document.